Potency and selectivity of a urokinase activated recombinant anthrax toxin to acute myeloid leukemia (AML) cells. (c2015)
Acute myeloid leukemia (AML) is a disorder characterized by uncontrolled mitogenetic activation and proliferation of hematopoietic precursor cells. Up to 30 % of adult patients with AML do not achieve complete remission when treated using chemotherapy. In addition, severe side effects usually limit...
Saved in:
| Main Author: | Darwich, Manal El. (author) |
|---|---|
| Format: | masterThesis |
| Published: |
2016
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10725/3598 https://doi.org/10.26756/th.2015.53 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The mechanisms of resistance of anthrax lethal toxin (LeTx)-induced cytotoxicity in AML cells. (c2018)
by: Abou Harb, Monica
Published: (2018) -
Sensitivity of acute myeloid leukemia cells to the dual targeting of the urokinase plasminogen activator and the MAPK pathway by a urokinase-activated anthrax lethal toxin. (c2013)
by: Bekdash, Amira
Published: (2013) -
Targeting human acute myeloid leukemia cells using human recombinant arginase I (Co) - PEG5000 [HuArgl (Co) - PEG5000] - induced arginine depletion. (c2013)
by: Tanios, Rita Farid
Published: (2013) -
Targeting the MAP Kinase pathway in human acute myeloid leukemia cells using a recombinant anthrax lethal toxin. (c2013)
by: Kassab, Elias
Published: (2013) -
In Vitro and In Vivo Effects of Lebanese Cannabis Oil Against Acute Myeloid Leukemia (AML)
by: Lteif, Anthony
Published: (2023)